NCT05358860View on ClinicalTrials.gov

Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Acne Scars - Mixed Atrophic and Hypertrophic
Interventions
DEVICE

Sofwave

The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.

Trial Locations (4)

10003

UnionDerm, New York

10016

Laser & Skin Surgery Center of New York®, New York

10028

New York Laser & Skin Care, New York

07601

SLSS, a Division of Schweiger Dermatology Group Research Office, Hackensack

All Listed Sponsors
lead

Sofwave Medical LTD

INDUSTRY